CARTAZOLATE
UNII 8K93Z46WPY

Substance Identification & Data

This profile provides standardized clinical and technical data for Cartazolate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8K93Z46WPY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 34966-41-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

8K93Z46WPY

CAS Registry Number

34966-41-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CARTAZOLATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C15H22N4O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

IQNQAOGGWGCROX-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C171687

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

37015

Unique identification number in the NCBI database of chemical substances.

INN ID

3779

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c12c(ncc(c1NCCCC)C(=O)OCC)n(CC)nc2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cartazolate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.